Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Zhanhua Yonghao Pharmaceutical Technology Co., Ltd. is a specialized manufacturer of pharmaceutical and pesticide intermediates and Active Pharmaceutical Ingredients (APIs), based in Binzhou, Shandong Province, China. Established in 2011 as a subsidiary of Taizhou Yongfeng Chemical Industry Co., Ltd., the company operates a large-scale production facility in the Binhai Chemical Park covering approximately 93,000 square meters. The company is particularly recognized for its expertise in fluorinated chemistry and the production of key intermediates such as Diethyl p-toluene sulfonyloxy methyl phosphonate (DESMP), which is essential for the synthesis of the antiviral drug Tenofovir. Shandong Zhanhua Yonghao adheres to international quality standards, including GMP, ISO9001, and OHSAS18001, to serve the global pharmaceutical and agrochemical industries. Its operations encompass research, development, and commercial-scale manufacturing of fine chemicals and specialized APIs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Zhanhua Yonghao.